SIG
57
-3
CFG
38
-2
AMP
66
-4
CA
36
-4
D
60
5
EIX
69
3
BF.B
43
-7
WHR
55
-2
EMC
53
-3
MCO
80
2
XRX
52
-3
AME
57
-2
FE
55
5
MDT
53
-2
CL
58
2
ITW
62
-2
COST
56
3
HOG
50
6
DE
53
8
PGR
68
3
SIG
57
-3
CFG
38
-2
AMP
66
-4
CA
36
-4
D
60
5
EIX
69
3
BF.B
43
-7
WHR
55
-2
EMC
53
-3
MCO
80
2
XRX
52
-3
AME
57
-2
FE
55
5
MDT
53
-2
CL
58
2
ITW
62
-2
COST
56
3
HOG
50
6
DE
53
8
PGR
68
3
Financhill
Back

Biomarin Pharmaceutical Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
35

BMRN
Biomarin Pharmaceutical

Last Price:
70.70
Seasonality Move:
5.7%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
35
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $70.69. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $70.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.4 Sell
Relative Strength Index (14 RSI): 22.78 Sell
Chaikin Money Flow: -1009919 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.4 - 92.98) Sell
Bollinger Bands (100): (78.06 - 88.38) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.96 Sell
20-day SMA: 83.55 Sell
50-day SMA: 85.45 Sell
200-day SMA: 86.8 Sell
8-day EMA: 75.07 Sell
20-day EMA: 80.72 Sell
50-day EMA: 83.8 Sell
200-day EMA: 85.86 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):